Anticoagulation Reversal for ICH

June 24, 2019 00:26:09
Anticoagulation Reversal for ICH
Critical Care Perspectives in Emergency Medicine
Anticoagulation Reversal for ICH

Jun 24 2019 | 00:26:09

/

Show Notes

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50 percent at 1-year, with many left with significant residual deficits.  Patients with an ICH who are taking an oral anticoagulant medication tend to have larger ICH volumes, more frequent IVH, and a greater frequency of hematoma expansion.  In this podcast, we review the latest recommendations on reversing anticoagulant medications in patients with an ICH. This is information you can’t afford to miss!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

July 15, 2020 00:26:28
Episode Cover

TXA for GI Bleeds? The HALT-IT Trial

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in...

Listen

Episode 0

November 23, 2023 00:24:31
Episode Cover

Should We Be Placing REBOA?

REBOA is a relatively new and novel technique that in animal studies has demonstrated benefit in controlling hemorrhage.  However, the evidence for the efficacy...

Listen

Episode 0

April 20, 2022 00:20:58
Episode Cover

Low-Tidal Volume Ventilation in the ED - Does it Make a Difference?

Though low-tidal volume ventilation has been shown to decreased mortality in patients with ARDS, the use of these settings in mechanically ventilated ED patients...

Listen